Cargando…

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer is the most lethal form of gynecologic cancer. The prognosis is worse for patients with ovarian cancer who also develop a blood clot in their legs or lungs, known as a venous thromboembolism (VTE). Between 10-30% of women with ovarian cancer will develop a VTE but the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glassman, Deanna, Bateman, Nicholas W., Lee, Sanghoon, Zhao, Li, Yao, Jun, Tan, Yukun, Ivan, Cristina, Rangel, Kelly M., Zhang, Jianhua, Conrads, Kelly A., Hood, Brian L., Abulez, Tamara, Futreal, P. Andrew, Fleming, Nicole D., Afshar-Kharghan, Vahid, Maxwell, George L., Conrads, Thomas P., Chen, Ken, Sood, Anil K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946269/ https://www.ncbi.nlm.nih.gov/pubmed/35326647 http://dx.doi.org/10.3390/cancers14061496

Ejemplares similares

Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics
por: Handley, Katelyn F., et al.
Publicado: (2022)

Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors
por: Wong, Kwong-Kwok, et al.
Publicado: (2022)

Metabolomic Profile in Venous Thromboembolism (VTE)
por: Franczyk, Beata, et al.
Publicado: (2021)

Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients
por: Bateman, Nicholas W., et al.
Publicado: (2021)

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
por: Amin, A., et al.
Publicado: (2009)

Hokusai-VTE: Edoxaban for the treatment of venous thromboembolism
por: Said, Karim
Publicado: (2013)

Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes
por: Teng, P-N, et al.
Publicado: (2014)

Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues
por: Penick, Emily R., et al.
Publicado: (2022)

Blood Being Tricky: Anticoagulation-Resistant Venous Thromboembolism (VTE)
por: Tiperneni, Raghu, et al.
Publicado: (2022)

Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2016)

Brain proteomic atlas of alcohol use disorder in adult males
por: Teng, Pang-ning, et al.
Publicado: (2023)

Venous thromboembolism (VTE) risk assessment completion in psychiatric inpatients
por: Powell, Harriet, et al.
Publicado: (2021)

Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
por: Jerjes-Sánchez, Carlos, et al.
Publicado: (2021)

NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer
por: Phippen, Neil T., et al.
Publicado: (2016)

Venous thromboembolism (VTE) prophylaxis in severely injured patients: an international comparative assessment
por: Gunning, Amy C., et al.
Publicado: (2019)

Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2013)

Incidence of Symptomatic Venous Thromboembolism (VTE) in 8,885 Elective Total Hip Arthroplasty Patients Receiving Post-operative Aspirin VTE Prophylaxis
por: Coveney, Eamonn I, et al.
Publicado: (2023)

Jupiter microtubule‐associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers
por: Bateman, Nicholas W., et al.
Publicado: (2019)

A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
por: Mokhtari, Majid, et al.
Publicado: (2019)

Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
por: Ageno, Walter, et al.
Publicado: (2021)

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
por: de Winter, Maria A, et al.
Publicado: (2023)

Anticomplement therapy
por: Kulkarni, Prathit A, et al.
Publicado: (2008)

Platelets in pulmonary vascular physiology and pathology
por: Kroll, Michael H., et al.
Publicado: (2012)

Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry
por: Bateman, Nicholas W., et al.
Publicado: (2021)

Venous Thromboembolism (VTE) in Post-Prostatectomy Patients: Systematic Review and Meta-Analysis
por: Wani, Mudassir, et al.
Publicado: (2023)

Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals
por: Parks, Anna L., et al.
Publicado: (2022)

Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens
por: Hunt, Allison L., et al.
Publicado: (2021)

Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
por: Xiong, Wei, et al.
Publicado: (2023)

Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
por: Lee, Sanghoon, et al.
Publicado: (2020)

Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative
por: Streiff, Michael B, et al.
Publicado: (2012)

Meta-analysis and suggested guidelines for prevention of venous thromboembolism (VTE) in foot and ankle surgery
por: Calder, James D. F., et al.
Publicado: (2016)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
por: Klok, Frederikus A., et al.
Publicado: (2019)

Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry
por: Ohsumi, Shozo, et al.
Publicado: (2023)

Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
por: Yoshikawa, Takaki, et al.
Publicado: (2023)

Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
por: Okusaka, Takuji, et al.
Publicado: (2023)

Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre
por: Pelletier, Ryan
Publicado: (2021)

Heparin-induced thrombocytopenia among patients of a comprehensive cancer center
por: Wu, Weixin, et al.
Publicado: (2014)

Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective
por: Menter, David G., et al.
Publicado: (2022)

Ancestral characterization of 1018 cancer cell lines highlights disparities and reveals gene expression and mutational differences
por: Kessler, Michael D., et al.
Publicado: (2019)

The Edoxaban Hokusai VTE PEDIATRICS Study: An open‐label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease
por: van Ommen, Cornelia Heleen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_77sfb29m9qo0f0da6e06dlee94